Physician
Family Medicine
Dr. Mark D. Rojewski, MD
|
|
Give Review
Mark Rojewski is an expert in the field of Family Medicine. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received 1 awards: "Meaningful Use Stage 1 Certification". Dr. Mark D. Rojewski is a published MD. He published 35 publications, including: 'Following up on screening tests.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning.
- Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia.
- Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling.
- Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
- Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue?
- Following up on screening tests.
- Depolarization of mitochondria and activation of caspases are common features of arsenic(III)-induced apoptosis in myelogenic and lymphatic cell lines.
- Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
- The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.
- The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a.
- Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
- Antibodies to glycosylphosphatidyl-inositol anchored proteins (GPI-AP) in antithymocyte and antilymphocyte globulin: possible role for the expansion of GPI-AP deficien...
- Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2.
- Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
- Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
- Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.
- Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries.
- mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression.
- Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
- High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma.
- Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.
- Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential...
- RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.
- Effects of nilotinib on regulatory T cells: the dose matters.
- Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material.
- Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function a...
- Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes.
- Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic perip...
- Ewing's sarcoma cells with CD57-associated increase of tumorigenicity and with neural crest-like differentiation capacity.
- Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
- The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.
- Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitro.
- Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglob...
- Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.
Schools
Wayne State University
Bon Secours Cottage Health Sys
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Health Alliance
- Preferred PPO
- Humana
- Medicare MCR
- Priority PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
Education
-
Wayne State University School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1154341071 | |
| NPPES Provider LastName | ROJEWSKI | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 488431007 | |
| NPPES Provider State | MI | |
| Specialty Description | Family Practice | |
| Total Claim Count | 4022.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 245.0 | |
| Percent Opioid Claims | 6.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154341071 |
| Last Name Of The Provider | ROJEWSKI |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Shiva Rouhani, MD |
|
|
Dr. Thomas W. Longley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren R. Garr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. April K. Fischer, DO |
|
|
Dr. Theresa A. Zaleski, DO |
|
|
Dr. Samuel Vasiu II, DO |
|
|
Dr. Tania A. Alchalabi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis E. May, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas E. McLearon, MD
This Doctor is OpenDoctor Recommended.
|